The Oswaldo Cruz Foundation (Fiocruz) collaborative and open access web space at TGHN aims to strengthen networks and improve capacities for public health research regionally and globally, by providing a vibrant virtual environment where professionals, students and researchers can share experiences, knowledge, method tools and resources.
Fiocruz is the most prominent Institution of Science and Technology in Health in Latin America. Bound to the Ministry of Health, its mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Unified Health System (SUS, acronym in Portuguese for the Brazilian public health system) and the promotion of health and quality of life for the population.
Since 2015 Brazil has experienced the social repercussions of the Zika virus epidemic, thus raising a debate about: difficulties of diagnosis; healthcare access for children with Zika Congenital Syndrome (ZCS); ...
Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The impacts of the disease may be beyond the respiratory system, also affecting mental health. ...
Epidemics occur within the existing ecosystem of socioeconomic determinants of health, including class, gender, race, income, employment and individuals’ physical environment. The Zika virus epidemic (2014–2017) demonstrated disproportionate effects of ...
Abstract Data is becoming ever more critical and valuable for both scientists and health authorities searching for answers to the COVID-19 crisis. Due to difficulties in diagnosing this infection in ...
The 2015 to 2017 outbreak of Zika generated global attention on the risk of a spectrum of neurological disorders posed to women and their unborn children—including, but not limited to, ...
Abstract Background Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. ...
On March 11th, 2020, the World Health Organization (WHO) declared COVID-19 (the disease caused by the novel coronavirus SARS-CoV-2) a pandemic. As of this article's writing, more than 1.3 million ...
The emergence of Zika virus in 2015 challenged conventional ideas of mosquito-borne diseases, tested the resilience of health systems and embedded itself within local sociocultural worlds, with major implications for ...
The global spread of the 2019-nCoV is continuing and is fast moving, as indicated by the WHO raising the risk assessment to high. In this article, we provide a preliminary ...
Maíra Menezes (IOC/Fiocruz) The Laboratory for Respiratory Viruses and Measles of the Oswaldo Cruz Institute (IOC/Fiocruz) has been nominated Reference Laboratory of the World Health Organization (WHO) for Covid-19 in the Americas. After the formalization of the agreement between the ... Read more
Understanding the gendered dimensions of - COVID-19 - #InFocus
Watch the webinar in English
12/06/2020 Fiocruz The Institute of Technology in Immunobiological Products (Bio-Manguinhos/Fiocruz) is running a Brazilian project to develop a synthetic vaccine against the novel coronavirus (SARS-CoV-2). The studies are now advancing to a pre-clinical phase, in which safety aspects will be ... Read more
02/06/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), in a partnership with the University College London, in the United Kingdom, have developed a new protocol for the genetic sequencing of the novel coronavirus, the SARS-CoV-2. The methodology ... Read more
14/07/2020 Maíra Menezes (IOC/Fiocruz) Researchers of the Oswaldo Cruz Institute (IOC/Fiocruz) have identified a new strain of the influenza virus in a patient in the city of Ibiporã, in the southern state of Paraná. Analysis have pointed to the presence ... Read more
13/07/2020 Marlúcia Seixas (Fiocruz Amazônia) Three lineages of the novel coronavirus have been introduced in the state of Amazonas, according to the study run by the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia), which investigated samples from the municipalities of ... Read more
Fiocruz researcher Gustavo Matta says "COVID deaths are not numbers"
WATCH (In portuguese)
15/07/2020 Nísia Trindade Lima, Paulo Marchiori Buss, Rômulo Paes-Sousa Originally published at Reports in Public Health In 2020, the COVID-19 pandemic has plunged nearly the entire planet into a health and humanitarian crisis, testing the human species in various dimensions. ... Read more
14/07/2020 Juana Portugal (INI/Fiocruz) The international clinical trial HPTN 083 has proven that PrEP (HIV pre-exposure prophylaxis) containing CAB-LA (long-acting injectable Cabotegravir) used every eight weeks yielded efficacy superior to Truvada in the prevention of infection by the virus. “This ... Read more
Follow the Fiocruz response and Brazilian actions and numbers regarding the COVID-19 pandemic.
Go to page
Available in English and Portuguese
The course presents general concepts of yellow fever, aimed at health professionals who work in primary healthcare. At the end of this course, you will be able to:
